The Safety of Glucagon use during ERCP in Diabetic Patients with Renal Insufficiency: A Case Discussion and Review of Literature
Anesthesia eJournal · 2018
DOI: 10.18776/50y5r380 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anesthesia eJournal, 2018. Verfasst von Lisa Erlinger und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
This is a case report with the use of glucagon during ERCP which resulted in Hyperkalemia. A 45 year old male, ASA 3, with Type 1 diabetes mellitus, hypertension, and chronic kidney disease underwent ERCP with general anesthesia for evaluation of a bile duct stricture. After administration of 0.75 mg glucagon (0.25 mg doses over an hour) tall, peaked T-waves were noted on the ECG. Labs were drawn and potassium was 6.6 mEq/L and glucose was 393 mg/dL. Intravenous calcium chloride, 1000 mg, was titrated. Repeat potassium was 6.1mEq/L and glucose 568 mg/dL. The remainder of the procedure was uneventful and postoperative potassium was 5.2 mEq/dL.
Zitieren
APA
Erlinger, L., PhD, CRNA, Monk, T., MD, MS, McAfee, S., & MD (2018). The Safety of Glucagon use during ERCP in Diabetic Patients with Renal Insufficiency: A Case Discussion and Review of Literature. Anesthesia eJournal. https://doi.org/10.18776/50y5r380
Vancouver
Erlinger L, PhD, CRNA, Monk T, MD, MS, et al. The Safety of Glucagon use during ERCP in Diabetic Patients with Renal Insufficiency: A Case Discussion and Review of Literature. Anesthesia eJournal. 2018. doi:10.18776/50y5r380
BibTeX
@article{Erlinger2018,
author = {Erlinger, Lisa and PhD and CRNA and Monk, Terri and MD and MS and McAfee, Steven and MD},
title = {The Safety of Glucagon use during ERCP in Diabetic Patients with Renal Insufficiency: A Case Discussion and Review of Literature},
journal = {Anesthesia eJournal},
year = {2018},
doi = {10.18776/50y5r380}
}
EUVIMED